Angeliki P Kourounakis

7PUBLICATIONS
6CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer cell biologyBiologically active moleculesPharmaceutical delivery technologiesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 15, 2025
Unraveling the Potential Pathogenic Role of Squalene Synthase (SQS) in Lung Cancer Using Enzyme Inhibitors as Molecular Tools.

Theodora Katavati, Filippos P Chatzipieris, Christiana Magkrioti

|Oct 07, 2025
The Contribution of Cholesterol and Squalene Synthase in Cancer: Molecular Mechanisms, Lipid Rafts and Therapeutic Approaches.

Danai Mavridi, Theodora Katavati, Angeliki P Kourounakis

|Dec 23, 2022
Contribution of Deep Learning in the Investigation of Possible Dual LOX-3 Inhibitors/DPPH Scavengers: The Case of Recently Synthesized Compounds.

Dimitrios Bakalis, George Lambrinidis, Angeliki Kourounakis

|Oct 02, 2022
Design of Improved Antidiabetic Drugs: A Journey from Single to Multitarget Agents.

Vassiliki-Panagiota Tassopoulou, Ariadni Tzara, Angeliki P Kourounakis

|Jun 20, 2020
New applications of squalene synthase inhibitors: Membrane cholesterol as a therapeutic target.

Angeliki P Kourounakis, Eugenia Bavavea

|Feb 05, 2020
Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies.

Ariadni Tzara, Dimitrios Xanthopoulos, Angeliki P Kourounakis

Pageof 2